We showed the epigenetic inactivation of RASSF10 in thyroid cancer [17], lung cancer [19], skin cancer [65], breast cancer [22] and showed that RASSF10 inhibited growth of breast cancer [22], pancreas carcinoma and sarcoma cell lines [19]. Here, RASSF10 is linked to lung carcinoma.